Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

peroralna raztopina

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

peroralna raztopina

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, pljučni pljuč - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - spolni hormoni in zdravila genitalni sistem, - oral contraceptive.

Evropska unija - slovenščina - EMA (European Medicines Agency)

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - spolni hormoni in zdravila genitalni sistem, - peroralna kontracepcija. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international nv - bosentan (as monohydrate) - hypertension, pulmonary; scleroderma, systemic - drugi antihipertenzivi - zdravljenje pljučne arterijske hipertenzije (pah) za izboljšanje telesne zmogljivosti in simptomov pri bolnikih s funkcionalnim razredu iii. svetovne zdravstvene organizacije (who). učinkovitosti je bilo prikazano v:primarne (idiopatsko in družinsko) pah;pah sekundarne za sklerodermijo brez večjih intersticijski pljučni bolezni;pah, povezane s prirojeno sistemsko-za-pljučna uporabo in eisenmenger je fiziologija. nekatere izboljšave so tudi pokazale, pri bolnikih s pah, ki funkcijski razred ii. stayveer je tudi navedeno, da se zmanjša število novih digitalnih razjede pri bolnikih s sistemsko sklerozo in tekoče digital-razjede bolezni.

Slovenija - slovenščina - Ecolab

ecolab deutschland gmbh -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaselect international, beteiligungs gmbh - flumazenil; protein s - raztopina za injiciranje/infundiranje - flumazenil 0,1 mg / 1 ml  protein s140 mg / 1 ml; protein s 140 mg / 1 ml - flumazenil

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - telmisartan - zastopniki, ki delujejo na renin-angiotensin sistem, angiotensin ii antagonisti, navaden - mačke - zmanjšanje proteinurije, povezane s kronično ledvično boleznijo (ckd).